The PennZone

  • Home
  • Non-profit
  • Books
  • Entertainment
  • Music
  • Marketing
  • Health
  • Legal
  • Artificial Intelligence

Screen, Quarantine and Monitor with MedWand's™ New, Cutting-Edge Telemedicine Kit: Mobile SQM DOC
The PennZone/10061410

Trending...
  • Affordable Braces in Allentown Made Accessible Through Exeter Smiles' Flexible Payment Options
  • PropAccount.com Launches Marketing Hub Within PropGenie, Giving Prop Firm Operators an Automated Marketing Team
  • New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
Medwand Sqm Doc
LAS VEGAS - PennZone -- The award-winning company and leader in telehealth, MedWand™ Solutions, Inc, has announced the debut of its latest creation in MedWand™ Kits: the Mobile Screen, Quarantine, Monitor (SQM) DOC. Equipped for the war against the spread of the coronavirus, Medwand's Mobile SQM unit includes a hand-held, cutting-edge, telehealth MedWand™ device that houses ten diagnostic tools, a UV sanitation device, a two-in-one touch screen tablet, wooden tongue depressors, and more, to provide a solution to help monitor and detect patients who are believed to, or already have, contracted the Covid-19 virus.

"MedWand has the ability to help save many lives and is easy to use. MedWand™ can help with triage, monitoring people in quarantine, and examining people for other conditions without bringing them into a potentially contaminated area," shared Samir Qamar, M.D., Co-Founder and CEO of MedWand™ Solutions. "It has web-based software with military-grade encryption - we have the right tool at the right time, and we can deploy it fast."

More on The PennZone
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Dave's Auto Services Launches Free Seven-Week Fall Maintenance Series for Boyertown-Area Drivers
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January

The MedWand™ device allows clinicians to conduct remote office visits, through the real-time collection of multiple vital sign readings and key patient assessments. It can listen to your heart and lungs, measure respiratory rates and blood oxygen levels, take your temperature, scan your skin and even look at your tonsils. All of this information gets sent in real time to your doctor who watches, listens, and interacts through a secure video portal on their computer.

The latest Medwand™ device kit, SQM DOC, offers monitoring with zero risk of infection, while tracking and monitoring trends in real-time. Each SQM DOC contains a sanitation device that uses UV technology, allowing a single MedWand™ to be used by multiple patients. The kit also includes anti-microbial wipes, sixty disposable wooden tongue depressors that can be inserted into the MedWand™ so the high-resolution camera can capture a clear photo of the back of the throat, the MedWand™ device, and a touchscreen tablet pre-configured and loaded with Medwand™ application to allow a real-time doctor visit. The mobile doc unit is packaged in a ruggedized protective carrying case.

More on The PennZone
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • Lehigh Valley's Kellyn Featured in National Film Series Exploring the Future of Diabetes Care
  • Top 100 Golf Coach Daniel Guest and Imagen Golf Announce Partnership with Remo Golf at Fairways Golf Club
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export

"MedWand™ has specific diagnostic instruments to remotely examine coronavirus patients, so we filed for an emergency use authorization with the FDA. We hope this will get approved quickly and should allow us to get these devices into the right hands, right away," added Dr. Qamar. "This is the future of healthcare. MedWand™ offers a solution to help stop the spread of contagious diseases."

MedWand™ is an award-winning device created by physicians and medical device engineers. The handheld product includes a stethoscope, otoscope, dermatoscope, throat illuminator with camera, IR thermometer, ECG, and pulse oximeter (SpO2, heart rate, respiratory rate). In addition to the Mobile SQM DOC, Medwand™ solutions also offers a Home DOC, Office DOC, and Mobile DOC. For more information on MedWand and the creators behind the device visit www.medwand.com. Pending clearance by the FDA. Not available for sale in all countries.

Follow us on Twitter

Like us on Facebook

Follow us on Instagram

Contact
VICTORIA ELDER
***@medwand.com


Source: MedWand Solutions, Inc.

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
  • "Warrior Defined" Event Brings Men Together in Charlotte, With Calls for Events Across the U.S
  • Dion Abadi Publishes Free Collector Tips Hub for Art and Jewelry Buyers
  • World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
  • ASN Software Introduces New California CARS Act Dealer Updates
  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
  • Mud Morganfield Bares His Soul on 7" Single, 'Deep Gospel'
  • Allstream Energy Partners, SEO Experts in Oil and Gas, Awarded Gas Processing OEM Agreement
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Jacqui Condon Selected to Workers' Compensation Panels for Three Professional Athlete Associations
  • New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
  • Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
  • Affordable Braces in Allentown Made Accessible Through Exeter Smiles' Flexible Payment Options
  • PropAccount.com Launches Marketing Hub Within PropGenie, Giving Prop Firm Operators an Automated Marketing Team
  • Save 15 Percent Off Florida Keys Accommodations with KeysCaribbean's Advance Purchase Rate Discount
  • Perfexion Inc. Named to the Philadelphia Business Journal's 2026 List of Largest Tech Employers

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 245
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 208
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 167
  • Brévant Guide Launches New National Restaurant Guide Across Canada - 135
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 121
  • OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors - 120
  • Expansive New Worlds Await Peter Darrach Unveils 'The Cleopard and Other Tales from the Second Skin - 104
  • Comics Veteran on Return of Teenage Mutant Ninja Turtles Characters, 3-D Projects, Collaboration with Original 'Star Wars' Toy Engineer
  • Sensory Education launches new neuro-affirming psychoeducation book, Sensory Diversity
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)

Similar on PennZone

  • 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us